Innovating Works

EPIDEMIC

Financiado
Experimental Epidemiology in Ant Societies
The risks and impact of disease are exacerbated in social organisms, which live in dense groups wherein pathogens can rapidly propagate. Theoretical epidemiology predicts that disease dynamics will depend in large part on a group'... The risks and impact of disease are exacerbated in social organisms, which live in dense groups wherein pathogens can rapidly propagate. Theoretical epidemiology predicts that disease dynamics will depend in large part on a group's social interaction network, but empirical data are scarce. Experimental epidemiology is currently hampered by a lack of study systems that would enable a rigorous investigation of the causal link between network structure and disease transmission. I will tackle this question using a novel system, the clonal raider ant, a social insect whose unique biology affords unparalleled control over the main aspects of colony composition that are thought to modulate social network structure, and therefore, disease transmission. My approach will combine cutting-edge automated techniques for behavioral tracking with molecular tools, and develop new methods to monitor transmission in real time. In a first step, I will create empirical networks that are theoretically predicted to vary in transmission risk and map individual immune function onto these networks, to measure the prophylactic network properties that might reduce disease transmission. Second, I will test if experimental increases in immune activity induce changes in behavior that are relevant for disease transmission, to measure inducible network properties. Finally, I will inoculate colonies with nematodes and quantify infection propagation in real time. This will allow me to compare various types of social networks (healthy, immune-activated, infected), to probe the link between behavior and immunity, and to experimentally test predictions from theoretical epidemiology. This project takes an integrative approach—from individual immunity to collective behavior—to uncover the properties of social groups that protect them against disease. By linking theoretical epidemiology to real-world disease dynamics, it will push the limits of our ability to predict disease dynamics in social groups. ver más
31/01/2026
MPG
2M€
Duración del proyecto: 73 meses Fecha Inicio: 2019-12-04
Fecha Fin: 2026-01-31

Línea de financiación: concedida

El organismo H2020 notifico la concesión del proyecto el día 2019-12-04
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
ERC-2019-STG: ERC Starting Grant
Cerrada hace 6 años
Presupuesto El presupuesto total del proyecto asciende a 2M€
Líder del proyecto
MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSE... No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5